Daiwa Research lowered its target price for Health and Happiness (H&H) International (01112) to HK$54 from HK$61.2 and maintained its "buy" rating.
The research house cited management from 1H post-results briefing targeting positive
revenue growth for adult nutrition (ANC) in 2019. H&H aims to maintain its selling-cost ratio steady in 2H while continuing to invest in brand and marketing for new products.
It also plans to gradually boost its dividend payout, with an improving balance sheet and strong operating cash flow.
In light of weak 7-month revenue growth and marketing expenses for 2H 2019-2021, Daiwa cut its revenue estimates by 6-8% and EPS forecasts by 5-11% over 2019-21.
全新節目《說說心理話》青少年不可以戀愛！？真實個案講述驚心動魄經歷► 即睇
